[1]
V., R.B., K., N.G., N., S.G., P., D., Nagaral, J.V., N., M. and R., D.C. 2019. Comparison of safety and toxicity of liposomal versus conventional Doxorubicin: an updated review. International Journal of Basic & Clinical Pharmacology. 8, 6 (May 2019), 1453–1459. DOI:https://doi.org/10.18203/2319-2003.ijbcp20192220.